These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19465557)

  • 1. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis.
    Jones LK; O'Sullivan KM; Semple T; Kuligowski MP; Fukami K; Ma FY; Nikolic-Paterson DJ; Holdsworth SR; Kitching AR
    Nephrol Dial Transplant; 2009 Oct; 24(10):3024-32. PubMed ID: 19465557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C5 mediates experimental tubulointerstitial fibrosis.
    Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
    J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage accumulation and renal fibrosis are independent of macrophage migration inhibitory factor in mouse obstructive nephropathy.
    Rice EK; Nikolic-Paterson DJ; David JR; Bucala R; Metz CN; Atkins RC; Tesch GH
    Nephrology (Carlton); 2004 Oct; 9(5):278-87. PubMed ID: 15504140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
    Nambu A; Nakae S; Iwakura Y
    Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment.
    Kitching AR; Turner AL; Wilson GR; Semple T; Odobasic D; Timoshanko JR; O'Sullivan KM; Tipping PG; Takeda K; Akira S; Holdsworth SR
    J Am Soc Nephrol; 2005 Jul; 16(7):2023-33. PubMed ID: 15888563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.
    Ma FY; Flanc RS; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
    J Am Soc Nephrol; 2007 Feb; 18(2):472-84. PubMed ID: 17202416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
    Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
    Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of an IL-1alpha vaccine depends on IL-1RI availability and concomitant myeloid-derived suppressor cell reduction.
    Weiss T; Vitacolonna M; Zöller M
    J Immunother; 2009; 32(6):552-64. PubMed ID: 19483654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model.
    Kim W; Moon SO; Lee SY; Jang KY; Cho CH; Koh GY; Choi KS; Yoon KH; Sung MJ; Kim DH; Lee S; Kang KP; Park SK
    J Am Soc Nephrol; 2006 Sep; 17(9):2474-83. PubMed ID: 16885409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy.
    Nishida M; Okumura Y; Sato H; Hamaoka K
    Nephrol Dial Transplant; 2008 Aug; 23(8):2520-4. PubMed ID: 18515792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo.
    Meier M; Menne J; Park JK; Holtz M; Gueler F; Kirsch T; Schiffer M; Mengel M; Lindschau C; Leitges M; Haller H
    J Am Soc Nephrol; 2007 Apr; 18(4):1190-8. PubMed ID: 17360953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction.
    Uchida Y; Miyajima A; Kikuchi E; Kozakai N; Kosaka T; Ieda M; Fukuda K; Ohigashi T; Oya M
    Urology; 2009 Oct; 74(4):938-43. PubMed ID: 19428059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney.
    Shimizu K; Furuichi K; Sakai N; Kitagawa K; Matsushima K; Mukaida N; Kaneko S; Wada T
    Hypertens Res; 2011 Jun; 34(6):747-52. PubMed ID: 21451526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I.
    Joosten LA; Van De Veerdonk FL; Vonk AG; Boerman OC; Keuter M; Fantuzzi G; Verschueren I; Van Der Poll T; Dinarello CA; Kullberg BJ; Van Der Meer JW; Netea MG
    APMIS; 2010 Dec; 118(12):1000-7. PubMed ID: 21091783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis.
    Khalil A; Tullus K; Bakhiet M; Burman LG; Jaremko G; Brauner A
    J Urol; 2000 Jul; 164(1):186-91. PubMed ID: 10840457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice.
    Labow M; Shuster D; Zetterstrom M; Nunes P; Terry R; Cullinan EB; Bartfai T; Solorzano C; Moldawer LL; Chizzonite R; McIntyre KW
    J Immunol; 1997 Sep; 159(5):2452-61. PubMed ID: 9278338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1 inflammatory response with altered expression of profibrotic and vasoactive mediators in AT1A and AT1B double-knockout mice.
    Ouyang X; Le TH; Roncal C; Gersch C; Herrera-Acosta J; Rodriguez-Iturbe B; Coffman TM; Johnson RJ; Mu W
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F902-10. PubMed ID: 15928210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose and interleukin-1beta downregulate interleukin-1 type I receptor (IL-1RI) in retinal endothelial cells by enhancing its degradation by a lysosome-dependent mechanism.
    Aveleira C; Castilho A; Baptista F; Simões N; Fernandes C; Leal E; Ambrósio AF
    Cytokine; 2010 Mar; 49(3):279-86. PubMed ID: 20034811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular trafficking of interleukin-1 receptor I requires Tollip.
    Brissoni B; Agostini L; Kropf M; Martinon F; Swoboda V; Lippens S; Everett H; Aebi N; Janssens S; Meylan E; Felberbaum-Corti M; Hirling H; Gruenberg J; Tschopp J; Burns K
    Curr Biol; 2006 Nov; 16(22):2265-70. PubMed ID: 17113392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
    Lu P; Li L; Liu G; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.